Fosaprepitant Interactions
There are 433 drugs known to interact with fosaprepitant, along with 1 disease interaction. Of the total drug interactions, 70 are major, 342 are moderate, and 21 are minor.
- View all 433 medications that may interact with fosaprepitant
- View fosaprepitant disease interactions (1)
Most frequently checked interactions
View interaction reports for fosaprepitant and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Adriamycin (doxorubicin)
- Alimta (pemetrexed)
- Aloxi (palonosetron)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Diflucan (fluconazole)
- Dilaudid (hydromorphone)
- Eliquis (apixaban)
- Enhertu (fam-trastuzumab deruxtecan)
- Excedrin Extra Strength (acetaminophen / aspirin / caffeine)
- Faslodex (fulvestrant)
- Fentanyl Transdermal System (fentanyl)
- Imitrex (sumatriptan)
- Imodium (loperamide)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Neulasta (pegfilgrastim)
- Tagrisso (osimertinib)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Fosaprepitant disease interactions
There is 1 disease interaction with fosaprepitant which include:
More about fosaprepitant
- fosaprepitant consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NK1 receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.